This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Pittcon 2013 Marks The Debut Of Thermo Fisher Scientific's New Chromeleon 7.2, A Landmark Software That Offers Functionality On Both Chromatography And Mass Spectrometry Devices, As Well As Enterprise-wide Network Functionality. (Graphic: Business Wire)
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it is launching significant innovations in software, instruments, consumables and services that unify its industry-leading analytical instrument platforms and enable customers to turn data into knowledge faster and more reliably.
“We’re pleased to extend our legacy of developing the most powerful analytical tools in the industry,” said Marc N. Casper, president and chief executive officer of Thermo Fisher Scientific. “Especially significant this year is that we’re helping our customers to better leverage that power by launching new software systems to make it easier for them to turn data into valuable knowledge. By unifying instrument platforms on a single data system, we are helping our customers to analyze information more quickly, speeding results and accelerating the pace of discovery and applied science.”
During the annual Pittsburgh Conference and Exhibition, Thermo Fisher is showcasing advancements in laboratory software alongside new instruments and consumables for uses ranging from life sciences discovery to food and water quality. The company will highlight how it fulfills its mission – to enable its customers to make the world healthier, cleaner and safer – through the capabilities of its three premier brands: Thermo Scientific
(Booth 1835), Fisher Scientific
and Unity Lab Services
(Booths 1924 and 1925). Pittcon is being held from March 17-21 at the Philadelphia Convention Center.
Turning Laboratory Data to Knowledge
Pittcon marks the global release of
Thermo Scientific Chromeleon™ ver. 7.2software, a milestone upgrade of the gold standard in chromatography data systems. For the first time, Chromeleon 7.2 unites mass spectrometry and chromatography instruments. Chromeleon software now supports Thermo Scientific mass spectrometers, including the ISQ single-quadrupole GC-MS and the TSQ-8000 GC-MS/MS. It also allows instruments to be integrated on enterprise-wide networks, making it the ideal solution for large universities and pharmaceutical researchers to facilitate collaboration between labs.
To further optimize laboratory assets, Thermo Fisher also introduces
Unity Lab SmartCapture Asset Utilization Monitoring for automated support, service and maintenance, regardless of the instrument manufacturer. This new offering – a combination of software enhancements and Unity Lab Services programs – allows laboratory operators to determine which instruments may be under- or over-utilized, determine optimal schedules, and plan for downtime and servicing. In addition, the newest generation of the company’s industry-leading LIMS platform,
Thermo Scientific SampleManager LIMS™ 11software, offers process mapping, management and automation to improve efficiency in computerized lab processes.
Accelerating Research and Discovery
Scientists have a growing interest in analyzing large molecules, such as nucleic acids and proteins, as well as monoclonal antibodies and amino acids, to unlock the potential of new techniques to diagnose and treat disease. To enable analyses of these targets, Thermo Fisher has developed the
Thermo Scientific Dionex UltiMate™ 3000 Biocompatible Rapid Separation (BioRS)system, combining ultra-high performance liquid chromatography (UHPLC) with a corrosion-resistant flow path that can withstand high salt or extreme pH conditions typical of this type of research. The system is ideally suited to support biopharmaceutical research, as well as quality assurance and control.
Specifically geared toward understanding therapeutic proteins, the new
Thermo Scientific Dionex GlycanPac AXH-1 HPLC column allows for better analysis of glycans – carbohydrates that may act as potential biomarkers or as post-translational modifications of therapeutic proteins. This improved means of separation and analysis allows researchers to create new categories of protein- and antibody-based therapeutics for disease.
Understanding complex biological chemicals such as dopamine and serotonin can help biopharmaceutical researchers better understand conditions such as Parkinson’s disease. To support this important research, the company has unveiled the
Thermo Scientific Dionex UltiMate 3000 Electrochemical Detector, combining the speed and resolution of UHPLC with high-sensitivity, femtogram-level electrochemical detection.
Speeding Results in Applied Markets
Increasingly strict regulatory standards for food, soil and drinking water worldwide demand the detection of lower levels of harmful trace elements, such as lead, mercury and chromium. To meet the need for increased sensitivity, Thermo Fisher introduces the
Thermo Scientific iCAP 7000 family of inductively coupled plasma-optical emission spectrometers (ICP-OES) – the newest generation of its highly successful iCAP platform. With a unique high-resolution charged injection device (CID) imager, the platform offers improved trace elemental analysis workflows, speed and cost with a focus on productivity and flexibility.
Thermo Scientific TRACE™ 1310 gas chromatograph has been enhanced with the addition of the
Thermo Scientific AI/AS 1310 Autosampler for higher throughput of environmental samples. More than 100 samples can be loaded at a time to enable larger industrial and contract laboratories to speed their time-to-results while analyzing components ranging from dangerous PCBs in food packaging to carcinogenic benzene and toluene in gasoline.
Thermo Fisher also combined software, consumables and instruments to create a simple, turnkey pesticide analysis solution, the
Thermo Scientific TSQ-8000 Pesticide Analyzer.
Thermo Scientific PicoSpin™ 45 spectrometer – a
2012 R&D 100 Award winner – is designed for applied analysis in laboratories of any size. The miniature NMR spectrometer’s small footprint and lower cost also make it a good choice for high school and college laboratories.
Continuing the trend toward easier-to-operate instruments that provide precise results, the push-button
Thermo Scientific Nicolet™ iS50spectrometer, winner of the
Best New Analytical Instrument award at the 2012 Gulf Coast Conference, offers advanced analytical capabilities for the non-scientist. Ideal for analyzing polymers, rubbers, paints, foods, pharmaceuticals and forensic evidence, the device can be upgraded from an FT-IR system to multi-range device capable of ATR, Raman and NIR analysis without manually changing components.
For access to all Thermo Fisher news and product photos related to Pittcon 2013, please visit our online media room at
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. With revenues of $13 billion, we have approximately 39,000 employees and serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. We create value for our key stakeholders through three premier brands, Thermo Scientific, Fisher Scientific and Unity Lab Services, which offer a unique combination of innovative technologies, convenient purchasing options and a single solution for laboratory operations management. Our products and services help our customers solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Visit
The following constitutes a “Safe Harbor” statement under the Private Securities Litigation Reform Act of 1995: This press release contains forward-looking statements that involve a number of risks and uncertainties. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are set forth in the company’s Annual Report on Form 10-K for the year ended December 31, 2012, under the caption “Risk Factors,” which is on file with the Securities and Exchange Commission and available in the “Investors” section of our website under the heading “SEC Filings.” Important factors that could cause actual results to differ materially from those indicated by forward-looking statements include risks and uncertainties relating to: the need to develop new products and adapt to significant technological change; implementation of strategies for improving growth; general worldwide economic conditions and related uncertainties; dependence on customers' capital spending policies and government funding policies; the effect of exchange rate fluctuations on international operations; the effect of healthcare reform legislation; use and protection of intellectual property; the effect of changes in governmental regulations; and the effect of laws and regulations governing government contracts, as well as the possibility that expected benefits related to the acquisitions of PicoSpin may not materialize as expected. While we may elect to update forward-looking statements at some point in the future, we specifically disclaim any obligation to do so, even if estimates change and, therefore, you should not rely on these forward-looking statements as representing our views as of any date subsequent to today.